Selective cyclooxygenase-2 inhibitors stimulate glucose transport in L6 myotubes in a protein kinase Cδ-dependent manner

Keyphrases

• 4E-BP1 20%
• Activity State 20%
• C-Cbl 20%
• Cohen 20%
• COX-2 Inhibitors 100%
• Cyclooxygenase-2 60%
• Cyclooxygenase-2 Inhibitors 100%
• Dominant Negative 20%
• Enzymatic Activity 20%
• ERK2 20%
• Glucose Transport 100%
• Glucose Transporter 4 (GLUT4) 40%
• Glycogen Synthase Kinase 3 (GSK3) 20%
• Hexose Transporter 60%
• Hexose Uptake 60%
• Insulin 80%
• Insulin Receptor Substrate 1 (IRS1) 20%
• JNK1 20%
• Kinase Activity 20%
• L6 Myotubes 100%
• Mammalian Target of Rapamycin (mTOR) 100%
• Molecular Interactions 20%
• Myotubes 100%
• Negative Type 20%
• Niflumic Acid 20%
• Nimesulide 20%
• P38 Mitogen-activated Protein Kinase (p38 MAPK) 20%
• P70S6K 20%
• Pharmacological Inhibitors 20%
• Phosphoinositide 3-kinase (PI3K) 20%
• Phosphorylation State 20%
• Plasma Membrane 40%
• Prostaglandin-endoperoxide Synthase 2 (PTGS2) 40%
• Protein Kinase 100%
• Rapamycin 20%
• Reich 20%
• Rofecoxib 20%
• Selective COX-2 Inhibitors 20%
• Selective Inhibitor 20%
• Signal Transduction Pathway 20%
• Site-specific Phosphorylation 20%
• Threonine Phosphorylation 20%
• Tyrosine Phosphorylation 40%

Biochemistry, Genetics and Molecular Biology

• AMP-activated Protein Kinase 28%
• Cell Membrane 28%
• COX-2 Inhibitor 100%
• Cyclooxygenase 28%
• Enzyme Activity 14%
• Glucose Transport 100%
• Glucose Transporter 28%
• Hexose 42%
• Hexose Transport 42%
• Kinase 14%
• Mammalian Target of Rapamycin 71%
• Molecular Interaction 14%
• P38 Mitogen-Activated Protein Kinases 14%
• Phosphotransferase 14%
• Prostaglandin-Endoperoxide Synthase 2 14%
• Protein Kinase C 100%
• Rofecoxib 14%
• Threonine 14%
• Tyrosine Phosphorylation 28%